Bonomo L, Casato M, Afeltra A, Caccavo D
Department of III Clinica Medica, University of Rome Medical School.
Am J Med. 1987 Oct;83(4):726-30. doi: 10.1016/0002-9343(87)90904-1.
Seven patients with type II idiopathic mixed cryoglobulinemia were treated with recombinant human leukocyte interferon (alpha interferon). In all of them, a conspicuous reduction of circulating cryoglobulins was noted, together with a definite, remarkable improvement of the clinical pattern. The immunologic parameters (natural killer cell activity and phagocytosis, among others) improved as well; side effects were usually mild and transient. Increases in the cryoglobulin level occurred in a few cases, but they were at least partly sensitive to readministration of alpha interferon treatment. The favorable results obtained in these cases of idiopathic cryoglobulinemia seem to be consistent and prolonged.
7例II型特发性混合性冷球蛋白血症患者接受了重组人白细胞干扰素(α干扰素)治疗。所有患者均出现循环冷球蛋白显著减少,同时临床症状有明确且显著的改善。免疫参数(如自然杀伤细胞活性和吞噬作用等)也有所改善;副作用通常轻微且短暂。少数病例出现冷球蛋白水平升高,但至少部分对再次给予α干扰素治疗敏感。这些特发性冷球蛋白血症病例所获得的良好结果似乎是持续且持久的。